SCHEMBL31376019

SCHEMBL31376019

CC(C)N(c1ccc(Cl)cc1OCc1ccccc1)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 1/20 0.47
▸ PTGER1 P34995 6/20 0.46
▸ CYP19A1 P11511 2/20 0.46
▸ HTR2C P28335 2/20 0.45
▸ HTR2B P41595 2/20 0.45
▸ MRGPRX4 Q96LA9 3/20 0.45
▸ CCR5 P51681 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ MDM2 Q00987 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GPR55 Q9Y2T6 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27490796 0.81 PSEN1 (0.47) PTGER1CYP19A1
SCHEMBL22894882 0.75 PTGDR2 (0.58) SLC6A4PTGER1HTR2CHTR2BMRGPRX4
SCHEMBL6864347 0.75 MRGPRX4 (0.52) PTGER1MRGPRX4ALDH1A1MAPTHPGD
SCHEMBL17589345 0.75 MRGPRX4 (0.66) SLC6A4PTGER1HTR2CHTR2BMRGPRX4
SCHEMBL7751027 0.75 NPC1 (0.47) PTGER1CYP19A1MRGPRX4NPC1ALDH1A1
SCHEMBL31375948 0.74 PTGER1 (0.44) PTGER1
SCHEMBL27804380 0.73 SLC6A4 (0.52) SLC6A4PTGER1HTR2CHTR2BMRGPRX4
SCHEMBL27492548 0.73 PSEN1 (0.45) SLC6A4PTGER1MRGPRX4NPC1ALDH1A1
SCHEMBL7378150 0.73 ALDH1A1 (0.53) PTGER1CYP19A1MRGPRX4NPC1ALDH1A1
SCHEMBL7743982 0.73 ALDH1A1 (0.64) PTGER1CYP19A1MRGPRX4NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119219608-A Polycyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2024-12-31 — — CN disclosed
Send feedback